共查询到19条相似文献,搜索用时 46 毫秒
1.
疟疾是全球危害最严重的传染性疾病之一,尤其是在非洲,发病率与死亡率仍居高不下。抗药性的出现和发展使大多数现有抗疟药在临床上失去了效用,研究和开发新型抗疟药已成为当前疟疾防治研究的迫切需求。随着恶性疟原虫基因组测序的完成和对疟原虫生物学认知的不断深入,寻找抗疟新靶点的研究得以快速发展。嘧啶生物合成途径是经临床确证有效的抗疟靶点的典范。我们简要综述了近年来以恶性疟原虫嘧啶从头合成途径第四步关键酶——二氢乳清酸脱氢酶(DHODH)为靶点的抗疟新药研究。高通量筛选、药物化学等研究已获得若干对恶性疟原虫DHODH有选择性抑制作用的化合物结构,其中有些在恶性疟原虫体外培养试验中表现出了较强的抗疟作用,且其酶抑制活性与抗疟活性间具有良好的相关性。通过三唑并嘧啶类系列先导化合物的优化研究,已获得了具有良好代谢稳定性、对鼠疟模型有效的类似物。已有大量研究表明DHODH靶向抗疟药的研发具有广阔前景。 相似文献
2.
人二氢乳清酸脱氢酶(human dihydroorotate dehydrogenase, hDHODH)是催化嘧啶从头合成途径的一个关键酶。近年来,多种研究表明,抑制该酶可缓解类风湿性关节炎的症状。但该酶的抑制剂甚少,寻找该酶的高效抑制剂具有重要意义。本研究利用PCR技术扩增hDHODH基因,构建重组质粒pET-19b-hDHODH,并在大肠杆菌(Escherichia coli, E.coli ) BL21(DE3)中表达,获得可溶性蛋白质。用Ni2+-NTA亲和层析柱对蛋白质进行纯化,获得较高(90%)纯度的hDHODH蛋白,将蛋白质与抑制剂3-(5-乙硫基)-1H-1, 2, 4-三氮唑-3-)苯甲酸和底物DHO混合孵育。用Hampton试剂盒初筛晶体并用棋盘法进行优化,获得晶形完美、衍射能力很强的hDHODH蛋白复合物单晶。用X射线衍射晶体,用CCP4、Coot软件解析结构,获得hDHODH蛋白复合物晶体结构。从解析的结构中可以看出,抑制剂与蛋白质的吻合度非常高,且抑制剂通过亲水的羧基端与蛋白质356位和147位的酪氨酸形成氢键网络。抑制剂的5元环与蛋白质359位的亮氨酸和360位的苏氨酸相互作用,使抑制剂与蛋白质牢固结合。该复合物晶体结构的顺利解析,将为开发新型特异性抗类风湿性关节炎药物提供重要基础。 相似文献
3.
摘要:目的 从微生物次生代谢产物中筛选免疫相关疾病治疗药物重要靶点—-二氢乳清酸脱氢酶的抑制剂。方法 利用自建的快速、高效的二氢乳清酸脱氢酶抑制剂的高通量筛选方法,从4560株真菌菌株中筛选阳性菌株。阳性菌株的发酵产物进行分离纯化获得活性化合物,再通过对活性化合物的紫外、质谱、核磁等理化数据的分析进行结构鉴定。结果 筛选分离得到2个活性化合物F01WB-1315A和F01WB-1315B。F01WB-1315A对二氢乳清酸脱氢酶有强的抑制活性,IC50=0.07 μg/mL,于20 μg/mL浓度下对体外 相似文献
4.
《中国细胞生物学学报》2016,(5)
二氢乳清酸脱氢酶(dihydroorotate dehydrogenase,DHODH)是存在于线粒体内膜的一种含铁的黄素依赖酶,这种酶催化嘧啶核苷酸从头合成途径的第4步反应。而嘧啶核苷酸可用于DNA、RNA、糖蛋白和磷脂生物合成,对于细胞代谢和细胞增殖至关重要。近年来的研究表明,DHODH与多种肿瘤的发生、发展密切相关,抑制或下调DHODH可以降低肿瘤细胞增殖,诱导其凋亡或者增加其他靶点药物的抗肿瘤效果。该文结合所在实验室目前的研究成果及进展,就DHODH作为治疗恶性肿瘤靶点的相关机制及当前DHODH抑制剂的研究进展作一综述。 相似文献
5.
类胡萝卜素是一类超过700种的萜烯基团类不饱和化合物的总称,根据结构可分为胡萝卜素族和叶黄素族,具有较高的营养价值。八氢番茄红素脱氢酶是类胡萝卜素生物合成途径中的首要限速酶,它参与催化无色的八氢番茄红素转变成有色类胡萝卜素,发挥着中心调控作用。不同生物源的八氢番茄红素脱氢酶在功能上呈现多样性,在大多数蓝细菌,藻类和高等植物的类胡萝卜素生物合成途径中,由Crt P,Crt Q和异构酶Crt H或PDS,ZDS和异构酶Z-ISO、Crt ISO共同参与番茄红素的形成,而在大多数微生物中只有Crt I-type一种酶来完成八氢番茄红素的脱氢反应,且根据脱氢步骤的不同分别可生成链孢红素、番茄红素或脱氢番茄红素。本文阐述了不同生物源八氢番茄红素脱氢酶的基因分离与鉴定,功能多样性及表达调控机制等最新研究进展,并进行了进化分析,为八氢番茄红素脱氢酶的深入研究及利用基因工程策略生产类胡萝卜素的应用提供重要信息。 相似文献
6.
7.
雌马酚是大豆异黄酮的代谢产物,是一种天然的选择性雌激素受体调节剂,稳定性和生物学活性高。为实现雌马酚的微生物合成,采用模块途径工程策略,构建编码雌马酚合成关键酶基因 orf-1、orf-2和orf-3 的表达载体,成功用于转化酿酒酵母BY4741,得到工程菌株。结果表明,工程菌株有效表达了外源基因,并可将大豆异黄酮代谢中间体二氢大豆苷元转化为雌马酚。为构建从头合成雌马酚的微生物细胞工厂提供了重要科学参考。 相似文献
8.
内消旋-二氨基庚二酸脱氢酶不对称合成非天然的手性D-氨基酸是目前生物催化领域的研究热点。内消旋-二氨基庚二酸脱氢酶具有优良的立体选择性,利用其进行酶催化不对称合成光学纯的手性D-氨基酸,被广泛用于医药、食品、化妆品、精细化学品等领域。为了促进生物催化法在合成手性D-氨基酸方向的进一步发展,本文对内消旋-二氨基庚二酸脱氢酶催化合成D-氨基酸的现状进行了综述。重点介绍了Corynebacterium glutamicum、Ureibacillus thermosphaericus、Symbiobacterium thermophilum来源的内消旋-二氨基庚二酸脱氢酶在新酶的挖掘、催化性能、晶体结构解析、分子改造、功能与催化机制、合成D-氨基酸新途径等方面的研究进展,并对内消旋-二氨基庚二酸脱氢酶的未来研究方向及策略进行了展望。本综述将进一步加深人们对内消旋-二氨基庚二酸脱氢酶的认识,也为具有挑战性的生物合成任务提供信息借鉴。 相似文献
9.
该研究根据黄秋葵(Hibiscus esculentus L.)转录组测序获得的八氢番茄红素脱氢酶基因(HePDS)序列(GenBank登录号为MG372370)设计引物,克隆验证得到1条HePDS基因全长为2 020 bp cDNA,开放阅读框(ORF)包含1 686个碱基;预测其编码561个氨基酸,理论分子量为62.62 kD,等电点为8.155;编码的蛋白与海岛棉(Gossypium barbadense)、雷蒙德氏棉(Gossypium raimondii)、陆地棉(Gossypium hirsutum)同源蛋白的相似性均在93%以上,均含有1个保守的二核苷酸结合域和1个类胡萝卜素结合域,显示其高度的保守性。荧光定量PCR 分析表明,HePDS基因在黄秋葵根、茎、叶、花和果荚中均有表达;叶发育过程以嫩叶中表达最高,果实发育中以花后2 d表达量最高。类胡萝卜素含量随着叶、果实发育逐渐升高,成熟叶的含量最高,果实以花后4 d含量最高,且HePDS基因的表达与类胡萝卜素含量存在密切的相关性。该研究结果为进一步探讨HePDS基因的功能和调控机制,以及采用VIGS和CRISPR/Cas9技术开展黄秋葵基因功能的反向遗传学研究奠定了基础。 相似文献
10.
二氢硫辛酰胺脱氢酶(dihydrolipoamide dehydrogenase,DLDH)是线粒体3个α-酮酸脱氢酶复合物(丙酮酸脱氢酶复合物、α-酮戊二酸脱氢酶复合物、支链氨基酸脱氢酶复合物)的关键成分,属于吡啶依赖性二硫化物氧化还原酶类,对活性氮自由基(reactive nitrogen species,RNS)和活性氧自由基(reactive oxygenspecies,ROS)造成的氧化修饰非常敏感。本研究探索由Angeli盐所产生的RNS对DLDH的修饰作用及机制。将大鼠脑线粒体分离,与不同浓度的Angeli盐作用,应用分光光度计、蓝色胶、基于二维电泳的蛋白质组学等手段,测定DLDH酶活性。结果显示,Angeli盐呈浓度依赖性方式灭活DLDH,过氧亚硝酸盐在同样条件下对DLDH酶活性无抑制作用,说明Angeli盐对DLDH的作用可能是非随机的。由于Angeli盐在生理pH条件下可分解为硝基阴离子(nitroxyl anion,HNO)和一氧化氮(nitric oxide,NO),故进一步分析了Angeli盐对DLDH的灭活作用是否由HNO引起,结果证实确实如此。最后,二维电泳Western blot结果显示,Angeli盐对DLDH的灭活伴随着DLDH蛋白质的S-亚硝基硫醇形成,提示S-亚硝基硫醇化可能是导致DLDH酶失活的原因。综上,本研究为研究Angeli盐灭活DLDH的机制提供了新证据。 相似文献
11.
Artur T. Cordeiro Patricia R. Feliciano M. Cristina Nonato 《Acta Crystallographica. Section F, Structural Biology Communications》2006,62(10):1049-1051
Dihydroorotate dehydrogenases (DHODHs) are flavin‐containing enzymes that catalyze the oxidation of l ‐dihydroorotate to orotate, the fourth step in the de novo pyrimidine nucleotide synthesis pathway. In this study, DHODH from Leishmania major has been crystallized by the vapour‐diffusion technique using lithium sulfate as the precipitating agent. The crystals belong to space group P61, with unit‐cell parameters a = 143.7, c = 69.8 Å. X‐ray diffraction data were collected to 2.0 Å resolution using an in‐house rotating‐anode generator. Analysis of the solvent content and the self‐rotation function indicate the presence of two molecules in the asymmetric unit. The structure has been solved by the molecular‐replacement technique. 相似文献
12.
Gero A. M. and Coombs G. H. 1982. Pyrimidine biosynthetic enzymes in Babesia hylomysci. International Journal for Parasitology12: 377–382. The enzymes that catalyse the conversion of carbamylaspartate to UMP have been demonstrated in the rodent piroplasm, Babesia hylomysci and partially characterised. They were shown to be similar to the corresponding mammalian enzymes in that dihydroorotase, orotate phosphoribosytransferase and orotidine-5'-phosphate decarboxylase were soluble, whilst dihydroorotate dehyrogenase was membrane bound and appeared to be associated with a respiratory chain. Dihydroorotate dehydrogenase was found to have a Km (l-DHO) of 21 μm and a pH optimum of 7.8. It was inhibited by analogs of ubiquinone and several pyrimidines, dihydroazaorotate being the most effective (). It is concluded that Babesia parasites contain a functional de novo biosynthetic pathway for pyrimidines which provides a potential target at which to direct putative chemotherapeutic agents. 相似文献
13.
Paul Rowland Sofie Nrager Kaj Frank Jensen Sine Larsen 《Acta Crystallographica. Section D, Structural Biology》2000,56(5):659-661
Dihydroorotate dehydrogenases (DHODs) are flavin‐containing enzymes which catalyse the conversion of (S)‐dihydroorotate to orotate, the fourth step in the de novo biosynthesis of pyrimidine nucleotides. Two major families of DHODs have now been identified based on their amino‐acid sequence similarities. The two families differ in their reaction mechanisms, but structures are only known of enzymes belonging to family 1. DHOD from Escherichia coli is a typical member of family 2, which contains the membrane‐associated enzymes from Gram‐negative bacteria and eukaryotes. Yellow crystals grown of this enzyme belong to the space group P41212 or P43212. The unit‐cell parameters are a = b = 119.2, c = 294.3 Å. Owing to the rather large c axis, the currently available resolution of data is 2.2 Å. 相似文献
14.
Cester N. Rabini R.A. Tranquilli A.L. Lucarelli G. Salvolini E. Staffolani R. Amler E. Zolese G. Mazzanti L. 《Molecular and cellular biochemistry》1997,174(1-2):125-129
Pyrimidines and purine (deoxy)nucleotides are the building blocks of DNA and RNA. Nucleoside diphosphate sugars, e.g. UDP-glucose, are the reactive intermediates in the synthesis of nearly all glycosidic bonds between sugars.In mammals the requirement for pyrimidines is met by UMP de novo synthesis and, to a greater or lesser extent, by salvage of free nucleosides. The exceptional compartmentation of the de novo synthesis with respect to mitochondrially-bound dihydroorotate dehydrogenase ('DHOdehase' or 'DHODH', EC 1.3.99.11) is one focus of the present work. DHODH activity was determined by the dihydroorotate-dependent oxygen consumption or by the UV absorption of the product orotate with mitochondria isolated from rodent and porcine tissues. For comparison, the cytochrome c and choline-dependent oxygen consumption of mitochondria from different tissues was measured. The highest specific activity of the rat DHODH was found in liver (2.3 × 10-3 µmol/min × mg protein) > kidney > heart. The application of known enzyme inhibitors Brequinar Sodium and Leflunomide for DHODH and sodium cyanide for cytochrome c oxidase verified the specificity of the activity tests used. The relation of DHODH activity versus that of cytochrome c oxidase revealed the lowest ratios in heart mitochondria and the highest in liver mitochondria. Since disorders in the mitochondrial energy metabolism could entail severe impairment of pyrimidine biosynthesis via respiratory-chain coupled DHODH, it is suggested to include improvement of pyrimidine nucleotide status in therapy protocols. (Mol Cell Biochem 174: 125–129, 1997) 相似文献
15.
Wen-Ying Liu Mei-Mei Wang Ji Huang Hai-Juan Tang Hong-Xia Lan Hong-Sheng Zhang 《植物学报(英文版)》2009,51(9):825-833
In the present paper, we identified and cloned OsDHODH1 encoding a putative cytosolic dihydroorotate dehydrogenase (DHODH) in rice. Expression analysis indicated that OsDHODH1 is upregulated by salt, drought and exogenous abscisic acid (ABA), but not by cold. By prokaryotic expression, we determined the enzymatic activity of OsDHODH1 and found that overproduction of OsDHODH1 significantly improved the tolerance of Escherichia coli cells to salt and osmotic stresses. Overexpression of the OsDHODH1 gene in rice increased the DHODH activity and enhanced plant tolerance to salt and drought stresses as compared with wild type and OsDHODH1 -antisense transgenic plants. Our findings reveal, for the first time, that cytosolic dihydroorotate dehydrogenase is involved in plant stress response and that OsDHODH1 could be used in engineering crop plants with enhanced tolerance to salt and drought. 相似文献
16.
Wen-Ying Liu Mei-Mei Wang Ji Huang Hai-Juan Tang Hong-Xia Lan Hong-Sheng Zhang 《Acta Botanica Sinica》2009,(9):825-833
In the present paper, we identified and cloned OsDHODH1 encoding a putative cytosolic dihydroorotate dehydrogenase (DHODH) in rice. Expression analysis indicated that OsDHODH1 is upregulated by salt, drought and exogenous abscisic acid (ABA), but not by cold. By prokaryotic expression, we determined the enzymatic activity of OsDHODH1 and found that overproduction of OsDHODH1 significantly improved the tolerance of Escherichia coil cells to salt and osmotic stresses. Overexpression of the OsDHODH1 gene in rice increased the DHODH activity and enhanced plant tolerance to salt and drought stresses as compared with wild type and OsDHODHl-antisense transgenic plants. Our findings reveal, for the first time, that cytosolic dihydroorotate dehydrogenase is involved in plant stress response and that OsDHODH1 could be used in engineering crop plants with enhanced tolerance to salt and drought. 相似文献
17.
Darrell E. Hurt Joanne Widom Jon Clardy 《Acta Crystallographica. Section D, Structural Biology》2006,62(3):312-323
Membrane‐associated dihydroorotate dehydrogenase (DHODH) is an antimalarial therapeutic target without an effective inhibitor. Studies on human DHODH (HsDHODH) led to a structural mechanistic model in which respiratory quinones bind in a tunnel formed by the highly variable N‐terminus that leads to the flavin mononucleotide‐binding site. The therapeutic agents leflunomide (Arava) and brequinar sodium inhibit HsDHODH by binding in this tunnel. Plasmodium falciparum DHODH (PfDHODH) and HsDHODH have markedly different sensitivities to the two drugs. To understand the structural basis of this differential sensitivity and begin a structure‐based drug‐design cycle for PfDHODH inhibitors, the three‐dimensional structure (2.4 Å, R = 20.1%) of PfDHODH bound to the active metabolite of leflunomide was determined by X‐ray crystallography. Comparison of the structures of HsDHODH and PfDHODH reveals a completely different binding mode for the same inhibitor in these two catalytically identical enzymes and explains the previously observed species‐specific preferential binding. Because no effective inhibitors have been described for PfDHODH, this structure provides critical insight for the design of potential antimalarials. 相似文献
18.
Clement Agoni Elliasu Y. Salifu Geraldene Munsamy Fisayo A. Olotu Mahmoud Soliman 《化学与生物多样性》2019,16(12)
The quest for reliable dihydroorotate dehydrogenase (DHODH) inhibitors has engendered the discovery of potential therapeutic compounds at different stages of clinical trials. Although promising, high attrition rates and unfavorable bioactivities have limited their drug developmental progress. A recent structural modification of DSM265, a triazolopyrimidine‐based inhibitor, yielded DSM421, derived by the substitution of the SF5‐aniline group on DSM265 with a CF3‐pyridinyl moiety. Consequently, DSM421 exhibited improved pharmacological and pharmacokinetics attributes relative to DSM265. The improved bioactivity mediated by the CF3‐pyridinyl group leaves us with a curiosity to investigate underlying ligand‐binding mechanisms and dynamics using computational methods. Presented in this study are insights that clearly explain the effects of structural SF5‐aniline→CF3‐pyridinyl modifications on pfDHODH inhibition. Findings showed that the CF3‐pyridinyl group induced an optimal and stabilized positioning of DSM421 within the binding pocket, allowing for steady and strong intermolecular interactions which favored its stronger binding affinity as estimated and correlated with bioactivity data. These interactions consequently induced a pronounced stabilization of the structural conformation of pfDHODH by restricting residue motions, which possibly underpinned its enhanced inhibitory activity relative to DSM265. Active site interactions of the CF3‐pyrinidyl group with residues Ser236, Ile237, and Phe188 characterized by strong π–π stacking and halogen interactions also stabilized its positioning which altogether accounted for its enhanced inhibitory prowess towards pfDHODH. On the contrary, fewer and weaker interactions characterized DSM265 binding which could explain its relatively lower binding affinity. Findings will facilitate the design of novel pfDHODH inhibitors with enhanced properties. 相似文献
19.
M. Löffler 《Nucleosides, nucleotides & nucleic acids》2016,35(10-12):566-577
ABSTRACTOrotate (OA) is well-known as a precursor in biosynthesis of pyrimidines; in mammals it is released from the mitochondrial dihydroorotate dehydrogenase (DHODH) for conversion to UMP by the cytoplasmic UMP synthase enzyme. OA is also a normal part of the diet, being found in milk and dairy products, and it is converted to uridine for use in the pyrimidine salvage pathway predominantly in liver, kidney and erythrocytes. Early research into nutrition identified orotate as “vitamin B13,” and its use as a complex with organic cations or metal ions was promulgated in body-building, and in assisting therapies of metabolic syndromes. It has recently been established that the amelioration of gout by dairy products arises from the competition of orotate and urate at the hURAT1 transporter. The orotic aciduria that arises in children with defective UMP synthase can be rescued by oral uridine therapy, since UMP is the end-product and also a feedback inhibitor of the de novo pathway. In contrast, Miller (dysmorphology) syndrome is connected with defects in DHODH, and hence in the supply of OA, and cannot be helped by uridine. Other models of dysmorphisms are connected with enzymes early in the pyrimidine de novo pathway. We conclude that the OA molecule is itself required for the regulation of genes that are important in the development of cells, tissues and organisms. 相似文献